By Pandora. It took me a while to come to the decision to do it. I started by contacting my GP and speaking with an endocrinologist, both of whom told me that I should be concerned about losing my sex drive and my ability to orgasm. As you might imagine, I was extremely upset at the possibility. At the same time the little warning bell went off in my head: ding ding ding!!
Orchiectomy aka. Orchidectomy is a Male-to-Female Surgery procedure that removes the testicles. Orchiectomy results in sterility, and can reduce sex drive and masculine characteristics such as beard growth due to the loss of testosterone. Many trans women choose to have this procedure and no further GRS, such as Vaginoplasty. With Simple Orchiectomy, the incisions are made in the scrotum. The patient lies flat on an operating table with the penis taped against the abdomen.
Select PDF you would like to download from the options in the table below:. The SOC are based on the best available science and expert professional consensus. The overall goal of the SOC is to provide clinical guidance for health professionals to assist transsexual, transgender, and gender nonconforming people with safe and effective pathways to achieving lasting personal comfort with their gendered selves, in order to maximize their overall health, psychological well-being, and self-fulfillment. This assistance may include primary care, gynecologic and urologic care, reproductive options, voice and communication therapy, mental health services e. While this is primarily a document for health professionals, the SOC may also be used by individuals, their families, and social institutions to understand how they can assist with promoting optimal health for members of this diverse population.
The goal of hormone therapy in trans women is to reduce the endogenous effects of testosterone such as coarse body hair and facial hair; and to induce female secondary sex characteristics such as breast and hip development. Physiologically, this requires a suppression of endogenous androgens and the addition of estrogen. Spironolactone has traditionally been used preferentially as it was thought to have a superior safety profile. This practice has recently come into question as it has been noted that adequate anti-androgen effects are achievable at lower doses of cyproterone at which adverse effects are less likely. Thus the choice of anti-androgen should be made individually for each client based on their medical history and preference regarding respective side effect profiles.